Clinical Trials Search Tool

A Phase 3, Multicenter, Open-Label Extension Study of the Long-Term Safety of ARQ-151 Cream 0.15% and ARQ-151 Cream 0.05% in Subjects with Atopic Dermatitis

Disease/Condition: Atopic Dermatitis

Location: Gresham

Ages: 2 years and older

Enrollment Opens: 07-29-2021

Enrollment Closes: TBD


To assess long-term safety in a multicenter, open-label, single-arm study in subjects with atopic dermatitis treated with ARQ-151 cream 0.15% QD (subjects ≥ 6 years of age) or ARQ‑151 cream 0.05% QD (subjects 2 to 5 years of age) after completing one of three Phase 3 studies (ARQ-151-311, ARQ‑151‑312, or ARQ-151-315).

Study ID: ARQ-151-313

To Enroll: Contact Cyn3rgy Research at; 503-907-2179 ext. 4 or visit us on the web at

Posted by: Cyn3rgy Research |